Bank Julius Baer & Co
GILD icon

Bank Julius Baer & Co’s Gilead Sciences GILD Stock Holding History

Bank Julius Baer & Co’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$107M Buy
849,164
+834,260
+5,598% +$110M 0.28% 76
2026
Q1 		$2.08M Buy
14,904
+662
+5% +$92.7K 0.01% 308
2025
Q4 		$1.75M Sell
14,242
-4,174
-23% -$507K ﹤0.01% 333
2025
Q3 		$2.04M Buy
18,416
+4,758
+35% +$541K 0.01% 323
2025
Q2 		$1.51M Sell
13,658
-777
-5% -$82.7K ﹤0.01% 310
2025
Q1 		$1.62M Buy
14,435
+194
+1% +$20K 0.01% 294
2024
Q4 		$1.45M Sell
14,241
-36,080
-72% -$3.25M ﹤0.01% 290
2024
Q3 		$5M Sell
50,321
-635,884
-93% -$48.5M 0.02% 223
2024
Q2 		$50.4M Sell
686,205
-18,104
-3% -$1.21M 0.19% 80
2024
Q1 		$51.5M Buy
704,309
+8,929
+1% +$687K 0.2% 90
2023
Q4 		$56.3M Buy
695,380
+278,061
+67% +$21.6M 0.24% 88
2023
Q3 		$31.3M Buy
417,319
+23,313
+6% +$1.79M 0.18% 99
2023
Q2 		$30.4M Sell
394,006
-4,392
-1% -$350K 0.18% 100
2023
Q1 		$33.1M Buy
398,398
+31,129
+8% +$2.58M 0.21% 103
2022
Q4 		$31.5M Buy
367,269
+1,827
+0.5% +$145K 0.22% 96
2022
Q3 		$22.5M Buy
365,442
+1,831
+0.5% +$115K 0.17% 100
2022
Q2 		$22.5M Buy
363,611
+12,222
+3% +$757K 0.16% 98
2022
Q1 		$20.9M Buy
351,389
+5,111
+1% +$327K 0.13% 100
2021
Q4 		$25.1M Sell
346,278
-372
-0.1% -$25.6K 0.13% 106
2021
Q3 		$24.2M Sell
346,650
-18,177
-5% -$1.28M 0.15% 105
2021
Q2 		$25.1M Buy
364,827
+17,540
+5% +$1.17M 0.16% 110
2021
Q1 		$22.4M Sell
347,287
-8,532
-2% -$550K 0.17% 108
2020
Q4 		$20.7M Sell
355,819
-30,409
-8% -$1.83M 0.17% 100
2020
Q3 		$24.4M Sell
386,228
-72,455
-16% -$5.02M 0.24% 81
2020
Q2 		$35.3M Sell
458,683
-363,864
-44% -$27.9M 0.41% 56
2020
Q1 		$61.5M Buy
+822,547
New +$56.8M 1.42% 14

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank Julius Baer & Co's GILD Position: Q2 2026 in Review

Bank Julius Baer & Co increased its Gilead Sciences (GILD) stake by 5,598% in Q2 2026, buying an estimated $110M and bringing the position to 849,164 shares worth $107M. The position accounts for 0.28% of the portfolio, ranked #76.

Bank Julius Baer & Co first reported a position in GILD in Q1 2020 and has held it in 26 quarters since. 2,291 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Bank Julius Baer & Co held 849,164 shares of Gilead Sciences worth $107M as of Q2 2026.
  • Bank Julius Baer & Co bought 834,260 Gilead Sciences shares in Q2 2026, an estimated $110M.
  • Gilead Sciences made up 0.28% of Bank Julius Baer & Co's portfolio in Q2 2026, its #76 holding.
  • Bank Julius Baer & Co first reported a position in Gilead Sciences in Q1 2020 and has held it in 26 quarters since.
  • 2,291 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Bank Julius Baer & Co's 13F filing for Q2 2026, filed 10 Aug 2026.